Sexual Dysfunction: A Major Healthcare Issue

Tawseef Hassan Sheikh, Wasim Fayaz, Muddasir Ahmad Rather, Aqib Hussain Kumar, Shoket Hussain, Pankaj Chasta

Abstract


Sexual dysfunction is a major healthcare issue. Sexual dysfunction disorders affect both men and women. Despite its commonness, this disorder is often not addressed by healthcare providers or patients due to their private and awkward nature. Many people are ashamed to talk about sexual dysfunction, so they
hesitate to see a doctor about treatment. Physicians, researchers must move beyond their unease in order to appropriately address patients’ sexual problems and implement appropriate treatment. Over 150 million men in the US and 18–30 million (more than 40% of women and 30% of men) report some level of
dysfunction. It can occur at any age, but mostly sexual dysfunction occurs in people between the ages of 40 and 65 years. Impotence is emerging as a major cause of divorce in India, says a recent study, adding that around 20–30% marriages in India are breaking up for want of satisfaction in sexual life.15 Therefore, it deserves attention, consideration, proper investigation, and appropriate treatment. The aim of these guidelines is to present the current evidence for the diagnosis and treatment of patients suffering from sexual dysfunction.16,17


Keywords


Erectile dysfunction, Premature ejaculation, Dyspareunia, Vaginismus

Full Text:

PDF

References


https://www.healthline.com/health/erectiledysfunction/

common-causes-impotence#lifestylefactors.

https://pdfs.semanticscholar.org/d4c3/5dea1522d-

d3c218656b388a48be4d0e56b.pdf.3. Feldman HA, Goldstein I, Hatzichristou DG et al.

Impotence and its medical and psychosocial correlates:

results of the Massachusetts Male Aging Study. J Urol.

Jan;.151(1):.54-61. http://www.ncbi.nlm.nih.gov/

pubmed/8254833,8 Male sexual dysfunction - update

march 2013.

Jackson G, Boon N, Eardley I et al. Erectile dysfunction

and coronary artery disease prediction: evidencebased

guidance and consensus. Int J Clin Pract 2010

Jun; 64(7): 848-57. http://www.ncbi.nlm.nih.gov/

pubmed/20584218.

Dong JY, Zhang YH, Qin LQ. Erectile dysfunction

and risk of cardiovascular disease: Meta-analysis of

prospective cohort studies. J Am Coll Cardiol 2011 Sep

; 58(13): 1378-85. http://www.ncbi.nlm.nih.gov/

pubmed/21920268.

Gupta BP, Murad MH, Clifton MM et al. The effect of

lifestyle modification and cardiovascular risk factor

reduction on erectile dysfunction: a systematic review

and meta-analysis. Arch Intern Med 2011 Nov 14;

(20): 1797-803. http://www.ncbi.nlm.nih.gov/

pubmed/21911624.

Guo W, Liao C, Zou Y et al. Erectile dysfunction and risk

of clinical cardiovascular events: A meta-analysis of

seven cohort studies. J Sex Med 2010 Aug; 7(8): 2805-

http://www.ncbi.nlm.nih.gov/pubmed/20367771.

Batty GD, Li Q, Czernichow S et al. Erectile dysfunction

and later cardiovascular disease inmen with type 2

diabetes: Prospective cohort study based on the

ADVANCE (Action in Diabetes and Vascular Disease:

Preterax and Diamicron Modified-Release Controlled

Evaluation) trial. J Am Coll Cardiol 2010 Nov 30; 56(23):

-13.

a.https://www.beaumont.org/conditions/male-femalesexual-

dysfunction-types.

Jardin A et al. The First International Consultation

on Erectile Dysfunction, Paris 1999. Jersey: Health

Publications Ltd 2000.

Feldman HA et al. Impotence and its medical and

psychological correlates: results from the Massachusetts

Male Ageing Study. J Urol 1994; 151: 54-61.

NIH Consensus Conference. Impotence. NIH Consensus

Development Panel on Impotence. JAMA 1993; 270:

-90.

Feldman HA, Goldstein I, Hatzichristou DG et al.

Impotence and its medical and psychosocial correlates:

results of the Massachusetts Male Aging Study. J Urol

; 151: 54-61.

Johannes CB, Araujo AB, Feldman HA et al. Incidence

of erectile dysfunction in men 40 to 69 years old:

longitudinal results from the Massachusetts Male Aging

Study. J Urol 2000; 163: 460-63.

http://www.thehealthsite.com/sexual-health/moreand-

more-indian-marriages-breaking-up-due-toerectile-

dysfunction.

Lindau ST et al. A study of sexuality and health among

older adults in the United States. N Engl J Med 2007;

(8): 762-74.

Rosenberg MT et al. Identification and diagnosis of

premature ejaculation. Int J Clin Pract 2007 61(6): p.

-8.

https://www.beaumont.org/conditions/male-femalesexual-

dysfunction.

NIH Consensus Conference. Impotence. NIH Consensus

Development Panel on Impotence. JAMA 1993; 270:

-90.

https://www.mayoclinic.org/diseases-conditions/

painful-intercourse/symptoms-causes/syc-20375967.

https://www.medicalnewstoday.com/articles/188527.

php.

https://my.clevelandclinic.org/health/diseases/9121-

sexual-dysfunction.

http://citeseerx.ist.psu.edu/viewdoc/download?-

doi=10.1.1.459.2984&rep=rep1&type=pdf.

Basson R, Althof S, Davis S et al. Summary of the

recommendations on sexual dysfunctions in women.

J Sex Med 2004; 1(1): 24-34.

https://www.beaumont.org/treatments/male-femalesexual-

dysfunction-prevention.

https://www.mayoclinic.org/diseases-conditions/

erectile-dysfunction/diagnosis-treatment/drc-

Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual

function: a critical review. J Clin Psychopharmacol 1999;

: 67–85.

Montejo-Gonzalez AL, Llorca G, Izquierdo JA et al. SSRIinduced

sexual dysfunction: fluoxetine, paroxetine,

sertraline, and fluvoxamine in a prospective, multicenter,

and descriptive clinical study of 344 patients. J Sex

Marital Ther 1997; 23: 176-94.

Balon R. Antidepressants in the treatment of premature

ejaculation. J Sex Marital Ther 1996; 22: 85-96.

Montague D. Guideline on pharmacologic management

of premature ejaculation. Available at: http://www.

auanet.org/content/clinical-practice-guidelines/clinicalguidelines.

cfm [accessed 24.01.13].

Schapiro B. Premature ejaculation, a review of 1130

cases. J Urol 1943; 50: 374-79.

Carson C, Wyllie M. Improved ejaculatory latency,

control and sexual satisfaction when PSD502 is applied

topically in men with premature ejaculation: results of

a phase III, double-blind, placebo-controlled study. J

Sex Med 2010; 7: 3179-89.

Safarinejad MR, Hosseini SY. Safety and efficacy of

tramadol in the treatment of premature ejaculation:

a double-blind, placebo-controlled, fixed-dose,

randomized study. J Clin Psychopharmacol 2006; 26:

-31.

34. Alghobary M, El-Bayoumy Y, Mostafa Y et al.

Evaluation of tramadol on demand vs. daily paroxetine

as a long-term treatment of lifelong premature

ejaculation. J Sex Med. 2010; 7:2860-67.35. Hoy SM, Scott LJ. Dapoxetine: in premature ejaculation.

Drugs 2010; 70: 1433-43.

Buvat J, Tesfaye F, Rothman M et al. Dapoxetine for

the treatment of premature ejaculation: results from

a randomized, double-blind, placebo-controlled phase

trial in 22 countries. Eur Urol 2009; 55: 957-67.

Sharlip ID. Guidelines for the diagnosis and management

of premature ejaculation. J Sex Med 2006; 3(Suppl. 4):

-17.

Althof SE, Abdo CHN, Dean J et al. International Society

for Sexual Medicine’s guidelines for the diagnosis and

treatment of premature ejaculation. J Sex Med 2010;

: 2947-69.

Gallo L, Perdona S, Gallo A. The role of short frenulum

and the effects of frenulectomy on premature

ejaculation. J Sex Med 2010; 7: 1269-76.

Kim JJ, Kwak TI, Jeon BG et al. Effects of glans penis

augmentation using hyaluronic acid gel for premature

ejaculation. Int J Impot Res 2004; 16: 547-51.

https://www.mayoclinic.org/diseases-conditions/

female-sexual-dysfunction/diagnosis-treatment/drc-


Refbacks

  • There are currently no refbacks.

Comments on this article

View all comments


Copyright (c) 2018 International Journal of Healthcare Education & Medical Informatics (ISSN: 2455-9199)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.